Drug Type CAR-T |
Synonyms- |
Target |
Mechanism GPRC5D inhibitors(G-protein coupled receptor family C group 5member D inhibitors), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plasma cell myeloma refractory | Phase 2 | CN | 07 Feb 2023 | |
Relapse multiple myeloma | Phase 2 | CN | 07 Feb 2023 |